Navigation Links
KII Standard Keratometer

ProductsKII Standard Keratometer
Company Marco Ophthalmic, Inc.
Item KII Standard Keratometer
Features 
  • Dual reading knobs (keratometer I) and internal readings (keratometer II) measure in both millimeters and diopters.
  • One position instrument. Measures both meridians without changing optical system.
  • Simple vertical adjustment to fit patient.
  • Two way adjustable head and chin rests.
  • Dual eye-level sighting system. Facilitates horizontal alignment.
  • Positive fixation.
  • Coincidence focusing system.
  • Description Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult.
    Info Marco Ophthalmic, Inc.
    Customer Service: (800) 874-5274
    Web site: http://www.marcooph.com/home.html

    Related medicine products :

    1. LM-101 Standard Lensmeter
    2. LM-201 Standard Lensmeter
    3. Standard Snellen Chart
    4. 3.5v Standard Ophthalmoscope
    5. Standard
    6. 11966R Standard Reading Test
    7. 11968R Standard Reading Test
    8. 11972R Standard Reading Test
    9. 11974R Standard Reading Test
    10. 11970R Standard Reading Test
    11. 11974CR Standard Reading Test
    Other Medicine News:Health News:The Pancreatic Cancer Research and Education Act Addresses the Astounding Mortality of the Fourth Leading Cause of Cancer Death in the United States 2Health News:The Pancreatic Cancer Research and Education Act Addresses the Astounding Mortality of the Fourth Leading Cause of Cancer Death in the United States 3Health News:Speed eClaim Helps National Dental Insurer United Concordia Process Claims Quickly, Efficiently and Electronically 2Health News:American Dietetic Association Calls for Accountability in Dietary Guidelines for Americans to Make Them More Effective 2Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 2Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 3Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 4Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 5Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 6Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 7Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 8Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 9Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 10Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 11Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 12Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 13Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 14Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 15Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 16Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 17Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 18Health News:Zimmer Reports Fourth Quarter and 2008 Financial Results 19Health News:The AFA's Infertility Prevention Series Premieres in NYC 2Health News:The AFA's Infertility Prevention Series Premieres in NYC 3Health News:Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers 2
    Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6National Medical Association Applauds President Obamas and Senator Baucuss Efforts to Work With PhRMA to Bring Down Health Care Costs and Advance Mean 49834 1USAID Brings White House Service Initiative to Baltimore 49829 1USAID Brings White House Service Initiative to Baltimore 49829 2USAID Brings White House Service Initiative to Baltimore 49829 3Cinergy Health Commentary On President Obamas Call for Cost Control Competition in Health Insurance Arena 49824 1Cinergy Health Commentary On President Obamas Call for Cost Control Competition in Health Insurance Arena 49824 2